Northern Trust Corp Alaunos Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.5 $534 - $2,227	-4,455 Reduced 1.01%	435,575 $56,000
Q2 2023 Aug 11, 2023	SELL	$0.43 - $0.65 $433 - $654	-1,007 Reduced 0.23%	440,030 $224,000
Q1 2023 May 15, 2023	BUY	$0.46 - $0.81 $7,135 - $12,564	15,512 Added 3.65%	441,037 $277,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $261.0 $533 - $278,487	-1,067 Reduced 0.25%	425,525 $276,000
Q3 2022 Nov 14, 2022	SELL	$1.04 - $322.5 $3,860 - $1.2 Million	-3,712 Reduced 0.86%	426,592 $734,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $709,214 - $2.14 Million	-1,729,791 Reduced 80.08%	430,304 $534,000
Q1 2022 May 13, 2022	SELL	$0.62 - $1.17 $108,492 - $204,735	-174,988 Reduced 7.49%	2,160,095 $1.41 Million
Q4 2021 Feb 08, 2022	BUY	$1.09 - $1.89 $184,148 - $319,304	168,944 Added 7.8%	2,335,083 $2.55 Million
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $187,629 - $355,713	-130,298 Reduced 5.67%	2,166,139 $3.94 Million
Q2 2021 Aug 13, 2021	SELL	$2.63 - $3.67 $199,824 - $278,842	-75,979 Reduced 3.2%	2,296,437 $6.06 Million
Q1 2021 May 12, 2021	SELL	$2.82 - $5.6 $250,774 - $497,991	-88,927 Reduced 3.61%	2,372,416 $8.54 Million
Q4 2020 Feb 11, 2021	SELL	$2.09 - $3.09 $348,306 - $514,960	-166,654 Reduced 6.34%	2,461,343 $6.2 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $246,987 - $354,463	-103,342 Reduced 3.78%	2,627,997 $6.62 Million
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $768,446 - $1.3 Million	349,294 Added 14.66%	2,731,339 $8.96 Million
Q1 2020 May 14, 2020	BUY	$1.9 - $4.98 $567,828 - $1.49 Million	298,857 Added 14.35%	2,382,045 $5.84 Million
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $157,407 - $213,197	39,850 Added 1.95%	2,083,188 $9.83 Million
Q3 2019 Nov 13, 2019	BUY	$4.13 - $6.94 $1.35 Million - $2.27 Million	327,053 Added 19.06%	2,043,338 $8.75 Million
Q2 2019 Aug 13, 2019	BUY	$3.98 - $6.2 $198,757 - $309,621	49,939 Added 3.0%	1,716,285 $10 Million
Q1 2019 May 13, 2019	BUY	$2.0 - $4.4 $37,184 - $81,804	18,592 Added 1.13%	1,666,346 $6.42 Million
Q4 2018 Feb 12, 2019	BUY	$1.61 - $3.62 $12,989 - $29,206	8,068 Added 0.49%	1,647,754 $3.08 Million
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $37,039 - $53,592	16,389 Added 1.01%	1,639,686 $5.25 Million
Q2 2018 Sep 18, 2018	SELL	$3.02 - $4.94 $28,131 - $46,016	-9,315 Reduced 0.57%	1,623,297 $4.9 Million
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $157,704 - $257,966	52,220 Added 3.3%	1,632,612 $4.93 Million
Q1 2018 May 09, 2018	BUY	$3.46 - $5.14 $33,485 - $49,744	9,678 Added 0.62%	1,580,392 $6.2 Million
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $204,248 - $333,945	-51,062 Reduced 3.15%	1,570,714 $6.5 Million
Q3 2017 Nov 13, 2017	BUY	$4.99 - $6.57 $8.09 Million - $10.7 Million	1,621,776	1,621,776 $9.96 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account